Type 2 & other diabetes

Impact of individual microvascular disease on the risks of macrovascular complications in type 2 diabetes: a nationwide population-based cohort study

Cardiovasc DiabetolPublished Population-based cohort study

Authors' conclusion

T2D patients with microvascular disease have a significantly higher risk of cardiovascular morbidities and mortality than those without microvascular disease. In the matched cohorts, diabetic neuropathy was significantly associated with stroke development, and diabetic retinopathy had a significant association with heart failure compared to other microvascular diseases.

Study context

Population
Newly diagnosed T2D patients, National Health Insurance Research Database, Taiwan, 2008–2019matched cohorts
Exposure
T2D with vs without microvascular disease; and between matched patients with DKD, DR or neuropathy
Outcome
Cardiovascular morbidity and mortality
Methodological detailsnationwide, propensity-score matched
  • Nationwide
  • Propensity-score matched

Main finding

As reported in the abstract

  • Significantly higher risk of cardiovascular morbidities and mortality with microvascular disease vs without

Observational data: associations, not effects.

Further findings

OutcomeaHR (95% CI)
Stroke development (matched cohorts)DRvs DKDMatched cohorts1.11 (1.03–1.2)
Stroke development (matched cohorts)Diabetic neuropathyvs DKDMatched cohorts1.17 (1.1–1.25)
Stroke development (matched cohorts)Diabetic neuropathyvs DRMatched cohorts1.12 (1.03–1.21)
Incident HF (matched cohorts)DRvs DKDMatched cohorts1.43 (1.3–1.57)
Incident HF (matched cohorts)Diabetic neuropathyvs DRMatched cohorts0.79 (0.71–0.87)

Original publication

Impact of individual microvascular disease on the risks of macrovascular complications in type 2 diabetes: a nationwide population-based cohort study. Cardiovasc Diabetol. Published 9 May 2023. doi:10.1186/s12933-023-01821-8

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.